home All News open_in_new Full Article

Hong Kong team develops test that detects nasopharyngeal cancer with 97% accuracy

Chinese University of Hong Kong researchers find patients with cancer-associated EBV DNA in blood have 87-fold increased risk of developing illness.



A Hong Kong research team at the Chinese University of Hong Kong developed a new blood screening method that uses sequencing technology to detect cancer-associated Epstein-Barr virus (EBV) DNA, identifying high-risk nasopharyngeal cancer patients with 97% accuracy. The study found individuals with cancer-associated EBV DNA in their blood had an 87-fold increased risk of developing the illness.

today 33 h. ago attach_file Politics

attach_file Events
attach_file Politics
attach_file Events
attach_file Events
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Science
attach_file Science
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Sport
attach_file Events


ID: 287110546
Add Watch Country

arrow_drop_down